MedPath

Effect of a drug named Dexmedetomidine on delirium in children in Cataract Surgeries after Anaesthesia

Phase 3
Completed
Conditions
Health Condition 1: null- Forty children, aged 2-10 years, otherwise healthy with no other diseases admitted under the Department of Ophthalmology, PGIMER will be enrolled for the study after appropriate evaluation.
Registration Number
CTRI/2014/06/004694
Lead Sponsor
PGIMER Chandigarh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

. Forty children, aged 2-10 years, belonging to American Society of Anaesthesiologists (ASA) I - II admitted under the Department of Ophthalmology, PGIMER will be enrolled for the study after appropriate evaluation.

Exclusion Criteria

Exclusion Criteria:

.Lack of consent

•Known adverse effects to dexmedetomidine

•History of seizures or mental retardation

•Developmental delay, or neurological or psychiatric illness that may associate with agitation (cerebral palsy, seizure, etc)

•Known endocrine disease

•A family history of malignant hyperthermia

• Emergency procedure

• Attention deficit hyperkinetic disorder

•Psychiatric illness

•History of paradoxical excitation with sedatives

•History of previous episode of emergence delirium

•preoperative EKG abnormality e.g. cardiovascular conduction disorder

• Recent upper respiratory tract infections.(URTI).

•Bleeding disorders / coagulation abnormalities.

•Associated anomalies demanding deviation from standard anaesthetic protocol(Airway abnormalities precluding use of Laryngeal Mask Airway, tumor or infection of the orbit, compromised sclera, single eye vision, raised IOP)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the effectiveness and safety of IV Dexmedetomidine (i.e. 0.15 µg/kg and 0.3µg/kg) for preventing desflurane induced emergence agitation in children undergoing cataract surgery under subtenon block.Timepoint: Different time intervals in Postoperative period
Secondary Outcome Measures
NameTimeMethod
To evaluate the recovery profile with these two doses.Timepoint: Different time intervals in Postoperative period
© Copyright 2025. All Rights Reserved by MedPath